RxDoctor Payments Data

Michael Pequeno

Nurse Practitioner · San Antonio, TXNPI 1467944256

Payments from drug & device makers

$5,634in general payments, 2019–2025

Across 171 payments — averaging $32.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Cvrx, Inc.$1K
  • Novartis$501
  • Merck$421
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$254
  • Impulse Dynamics (USA) Inc.$210
  • plus $1K from 16 others

What the payments were for

  • Travel & lodging$1,02018%
  • Food & beverage$4,61482%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,634 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.

See all nurse practitioner providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban81$108,766
EntrestoSacubitril/Valsartan29$54,580
FarxigaDapagliflozin Propanediol46$40,624
XareltoRivaroxaban18$23,838
ClopidogrelClopidogrel Bisulfate133$1,362
Carvedilol124$1,151
Metoprolol Succinate88$980
Atorvastatin Calcium70$677
Rosuvastatin Calcium51$597
Isosorbide Mononitrate ErIsosorbide Mononitrate54$518
Furosemide85$502
Nitroglycerin23$405
Losartan Potassium42$401
Amlodipine Besylate51$324
Nifedipine ErNifedipine11$283

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$501$54,58029 claims
AstraZenecaFarxiga$92$40,62446 claims
Johnson & JohnsonXarelto$210$23,83818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,422 nurse practitioner providers in Texas.

Other nurse practitioner in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →